“…However, recent advances in genome-wide association studies (GWAS) have provided a fairly good view of the contribution of APOA5 variants to dyslipidemia in several populations (Talmud, 2007 ; Li et al, 2014 ; Zubair et al, 2016 ; Kefi et al, 2017 ; Sumegi et al, 2017 ). The minor allele of several common APOA5 SNPs such as rs662799 (-1131T>C) and rs3135506 (S19W) have been reported to be consistently and significantly associated with plasma triglyceride (TG) levels (Baum et al, 2003 ; Chaaba et al, 2005 ) and the risk of cardiovascular disease (Talmud et al, 2002 ; Lai et al, 2004 ) in several populations.…”